Overview

Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether the novel aspiration thrombectomy device combined with catheter-directed thrombolysis is effective in the treatment of acute iliofemoral deep venous thrombosis (IF-DVT).
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Xuzhou Medical University
Treatments:
Calcium
Calcium heparin
Calcium, Dietary
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin
Criteria
Inclusion Criteria:

- Clinical diagnosis of iliofemoral deep venous thrombosis

- Symptoms of less than 14 days' duration

- With good function status

- A life expectancy of more than 1 year

- A low risk of bleeding

Exclusion Criteria:

- Without iliac vein thrombosis

- Anticoagulation and/or thrombolysis contraindications

- Systemic infection

- Heart, hepatic, renal function insufficiency